Skip to main content

Table 3 Study measurements by visit

From: KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods

  Parameter Screening Baseline 1 y 2 y 3 y 4 y 5 y 6 y 7 y 8 y 9 y 10 y
General Informed consent O            
Demographic information O            
Medical history O            
KNHANES questionnaire   O           
Recent events    O O O O O O O O O O
Medications   O O O O O O O O O O O
Kidney CBC, blood/urine chemistry   O O O O O O O O O O O
Kidney ultrasonographya   O O O O O O O O O O O
Isotopic GFR (optional)   O    O    O    O  
Growth Height, weight, waist/hip ratio, Tanner stage O O O O O O O O O O O
Bone age   O O O O O O O O O O O
Cardio-vascular Blood pressure   O O O O O O O O O O O
Electrocardiogram, chest X-ray O   O   O   O   O   O
Echocardiography   O      O      O
24-hour ambulatory blood pressure monitoring (optional) O O   O   O   O   O  
Metabolic bone disease Parathyroid hormone, vitamin D O O   O   O   O   O  
Bone mineral density   O      O      O
Neuro-cognitive Pediatric quality of life   O    O    O    O O
IQ testb    O    O    O    O
Behavioral assessmentc     O    O    O   
Parental bonding instrumentd   O           O
Bio-repository Genetic sample   O           
Serum/urine sample   O O O O O O O O O O O
  1. aKidney ultrasonography is performed annually for patients with CAKUT and every 3 years for other patients
  2. bKEDI-WISC (5–15 years) or K-WAIS (16 years or older) [33]. cChild Behavioral Checklist (CBCL) [34], ADHD Rating Scale-IV [35], State-Trait Anxiety Inventory (STAI) [36], and Children’s Depression Inventory (CDI) [37]. dParental bonding instrument [38]